Publication
Article Metrics
Citations
Online attention
Rapid recognition of drug-resistance/sensitivity in leukemic cells by Fourier transform InfraRed microspectroscopy and unsupervised Hierarchical Cluster Analysis.
Authors:
Giuseppe
Bellisola
(Azienda Ospedaliera Universitaria Integrata Verona (AOUI))
,
Gianfelice
Cinque
(Diamond Light Source)
,
Marzia
Vezzalini
(University of Verona)
,
Elisabetta
Moratti
(University of Verona)
,
Giovannino
Silvestri
(University of Verona)
,
Sara
Redaelli
(University of Milano-Bicocca)
,
Carlo
Gambacorti Passerini
(University of Milano-Bicocca)
,
Katia
Wehbe
(Diamond Light Source)
,
Claudio
Sorio
(University of Verona)
Co-authored by industrial partner:
No
Type:
Journal Paper
Journal:
Analyst
, VOL 138 (14)
State:
Published (Approved)
Published:
January 2013
Diamond Proposal Number(s):
6675
,
7143
Abstract: We tested the ability of Fourier Transform (FT) InfraRed (IR) microspectroscopy (microFTIR) in combination with unsupervised Hierarchical Cluster Analysis (HCA) in identifying drug-resistance/sensitivity in leukemic cells exposed to tyrosine kinase inhibitors (TKIs). Experiments were carried out in a well-established mouse model of human Chronic Myelogenous Leukemia (CML). Mouse-derived pro-B Ba/F3 cells transfected with and stably expressing the human p210BCR-ABL drug-sensitive wild-type BCR-ABL or the V299L or T315I p210BCR-ABL drug-resistant BCR-ABL mutants were exposed to imatinib-mesylate (IMA) or dasatinib (DAS). MicroFTIR was carried out at the Diamond IR beamline MIRIAM where the mid-IR absorbance spectra of individual Ba/F3 cells were acquired using the high brilliance IR synchrotron radiation (SR) via aperture of 15 × 15 ?m2 in sizes. A conventional IR source (globar) was used to compare average spectra over 15 cells or more. IR signatures of drug actions were identified by supervised analyses in the spectra of TKI-sensitive cells. Unsupervised HCA applied to selected intervals of wavenumber allowed us to classify the IR patterns of viable (drug-resistant) and apoptotic (drug-sensitive) cells with an accuracy of >95%. The results from microFTIR + HCA analysis were cross-validated with those obtained via immunochemical methods, i.e. immunoblotting and flow cytometry (FC) that resulted directly and significantly correlated. We conclude that this combined microFTIR + HCA method potentially represents a rapid, convenient and robust screening approach to study the impact of drugs in leukemic cells as well as in peripheral blasts from patients in clinical trials with new anti-leukemic drugs.
Subject Areas:
Biology and Bio-materials
Instruments:
B22-Multimode InfraRed imaging And Microspectroscopy
Added On:
10/01/2013 08:57
Discipline Tags:
Technical Tags: